Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized Control Trial of Arginine Therapy for Pediatric Sickle Cell Disease Pain

NCT02536170 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02536170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized Control Trial of Arginine Therapy for Pediatric Sickle Cell Disease Pain
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2016
Completion date
February 21, 2021
Enrollment
108 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, vaso-occlusive pain episode